1. Home
  2. VIR vs ASTL Comparison

VIR vs ASTL Comparison

Compare VIR & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ASTL
  • Stock Information
  • Founded
  • VIR 2016
  • ASTL 1902
  • Country
  • VIR United States
  • ASTL Canada
  • Employees
  • VIR N/A
  • ASTL N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ASTL Steel/Iron Ore
  • Sector
  • VIR Health Care
  • ASTL Industrials
  • Exchange
  • VIR Nasdaq
  • ASTL Nasdaq
  • Market Cap
  • VIR 706.4M
  • ASTL 733.5M
  • IPO Year
  • VIR 2019
  • ASTL N/A
  • Fundamental
  • Price
  • VIR $5.65
  • ASTL $6.23
  • Analyst Decision
  • VIR Strong Buy
  • ASTL
  • Analyst Count
  • VIR 8
  • ASTL 0
  • Target Price
  • VIR $30.25
  • ASTL N/A
  • AVG Volume (30 Days)
  • VIR 1.2M
  • ASTL 851.3K
  • Earning Date
  • VIR 08-04-2025
  • ASTL 07-29-2025
  • Dividend Yield
  • VIR N/A
  • ASTL 3.21%
  • EPS Growth
  • VIR N/A
  • ASTL N/A
  • EPS
  • VIR N/A
  • ASTL N/A
  • Revenue
  • VIR $20,861,000.00
  • ASTL $1,635,857,227.00
  • Revenue This Year
  • VIR N/A
  • ASTL $0.95
  • Revenue Next Year
  • VIR $0.62
  • ASTL $21.63
  • P/E Ratio
  • VIR N/A
  • ASTL N/A
  • Revenue Growth
  • VIR N/A
  • ASTL N/A
  • 52 Week Low
  • VIR $4.32
  • ASTL $4.17
  • 52 Week High
  • VIR $14.45
  • ASTL $12.14
  • Technical
  • Relative Strength Index (RSI)
  • VIR 54.74
  • ASTL 41.20
  • Support Level
  • VIR $5.31
  • ASTL $6.59
  • Resistance Level
  • VIR $5.92
  • ASTL $7.24
  • Average True Range (ATR)
  • VIR 0.30
  • ASTL 0.30
  • MACD
  • VIR 0.02
  • ASTL -0.12
  • Stochastic Oscillator
  • VIR 43.69
  • ASTL 24.06

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

Share on Social Networks: